Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”
Journal of Comparative Effectiveness Research · 2026-11 · 15 (11)
DOI: 10.57264/cer-2026-0183 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-11. Verfasst von Yinglei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: CSL Behring, King of Prussia, PA 19406, USA. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CSL Behring, King of Prussia, PA 19406, USA.
- CSL Behring AG, Bern, Switzerland.
- CSL Behring Lengnau AG, Lengnau, Bern, Switzerland.
- EVERSANA™, Victoria, BC V8W 2E1, Canada.
- EVERSANA™, New York, NY 10018, USA.
ORCID-Profile: Yinglei Li, Nicolas Scheuer, Sarah Walsh, Anja Haltner, Imtiaz A Samjoo
Zitieren
APA
Li, Y., Gavata-Steiger, S., Nenci, C., Scheuer, N., Walsh, S., Haltner, A., & Samjoo, I. A. (2026). Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”. Journal of Comparative Effectiveness Research, 15(11). https://doi.org/10.57264/cer-2026-0183
Vancouver
Li Y, Gavata-Steiger S, Nenci C, Scheuer N, Walsh S, Haltner A, et al. Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”. Journal of Comparative Effectiveness Research. 2026;15(11). doi:10.57264/cer-2026-0183
BibTeX
@article{Li2026,
author = {Li, Yinglei and Gavata-Steiger, Simona and Nenci, Chiara and Scheuer, Nicolas and Walsh, Sarah and Haltner, Anja and Samjoo, Imtiaz A},
title = {Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”},
journal = {Journal of Comparative Effectiveness Research},
year = {2026},
volume = {15},
number = {11},
doi = {10.57264/cer-2026-0183}
}
EUVIMED